Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
20/09/2025
Prime Minister of Mauritius: Central Bank Governor Sittanaun has been asked to resign.
Latest
2 m ago
In August, the number of aircraft takeoffs and landings at Singapore Changi Airport decreased by 1.3% year-on-year.
5 m ago
Singapore Changi Airport saw a 3.1% year-on-year increase in passenger traffic in August.
8 m ago
Novartis CEO Vas Narasimhan said in an interview on Saturday that the company is studying a plan to propose a price reduction to President Trump before the end of this month. Narasimhan said, "We are working with the government to find practical solutions so that the American people can buy drugs at lower prices." He added that the company is also working to eliminate the price gap between drugs in the United States and other industrialized countries. Narasimhan said that Novartis has not adjusted its expectations due to Trump's requests and still expects revenue to increase by 5% from mid-2024 to mid-2029, with profit growth outpacing revenue growth. Narasimhan also said that Novartis is prepared for the 15% tariff that the US imposes on drugs from the European Union, stating, "We have significantly increased our inventory in the United States, so this inventory should last until mid-2026."
8 m ago
Novartis CEO said that they are currently researching a price reduction plan for the US market in order to maintain revenue growth expectations.
23 m ago
Nearly a hundred types of rare disease drugs have been included in the medical insurance list, and the rare disease diagnosis and treatment cooperation network covers 31 provinces.
See all latest
